These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2498507

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
    Dupuy J, Price M, Lynch G, Bruce S, Schwartz M.
    J Am Acad Dermatol; 1993 Jun; 28(6):966-72. PubMed ID: 8496462
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
    Lane HC, Kovacs JA, Feinberg J, Herpin B, Davey V, Walker R, Deyton L, Metcalf JA, Baseler M, Salzman N.
    Lancet; 1988 Nov 26; 2(8622):1218-22. PubMed ID: 2903954
    [Abstract] [Full Text] [Related]

  • 9. Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon.
    Ganser A, Brücher W, Brodt HR, Busch W, Brandhorst I, Helm EB, Hoelzer D.
    Onkologie; 1986 Jun 26; 9(3):163-6. PubMed ID: 3018647
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
    Baumann R, Täuber MG, Opravil M, Hirschel B, Kinloch S, Chave JP, Pletscher M, Lüthy R.
    Klin Wochenschr; 1991 May 24; 69(8):360-7. PubMed ID: 1909399
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
    Mitrou PS, Fischer C, Huhn D, Rasokat H, Ring J, Bergmann L.
    Onkologie; 1988 Feb 24; 11(1):61-2. PubMed ID: 2452394
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Presentation of Kaposi's sarcoma in the acquired immune deficiency syndrome.
    Tom LA.
    Hawaii Med J; 1989 Apr 24; 48(4):131-4. PubMed ID: 2661499
    [Abstract] [Full Text] [Related]

  • 14. [Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma].
    Steger G, Dittrich C, Eichler HG, Flener R, Moser K.
    Wien Klin Wochenschr; 1987 Feb 20; 99(4):120-3. PubMed ID: 3577187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
    Mauss S, Jablonowski H.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct 01; 10(2):157-62. PubMed ID: 7552479
    [Abstract] [Full Text] [Related]

  • 19. A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.
    Zamkoff KW, Newman NB, Rudolph AR, Young J, Poiesz BJ.
    J Biol Response Mod; 1989 Oct 01; 8(5):539-52. PubMed ID: 2795095
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.